In a relief to Sanofi Pasteur India and GlaxoSmithKline Pharmaceuticals, the Competition Appellate Tribunal (Compat) has set aside an order levying fine on the firms by Competition Commission of India.
The CCI had found that Sanofi and GSK had cartelised in the supply of meningococcal vaccines (vaccines against meningitis), procured by the government for vaccinating Hajj pilgrims. According to a complaint, the firms coordinate among themselves the volumes that each would supply to the government.
CCI imposed a penalty of R3.04 crore on Sanofi and another R60.48 crore on GSK. This has now been set aside by the Compat, which also ordered that no proceedings for penalties on individual staff of the companies need to be taken.
Sanofi is represented by the former head of the CCI, Vinod Dhall and his team at Vinod Dhall-Talwar Thakore & Associates comprising associates Sonam Mathur, Mansi Tewari and Sanjeev Kumar. The case was argued by advocate Rajshekhar Rao.
GSK was represented by AZB & Partners’ competition team led by Sameer Gandhi and comprising associates Rahul Rai and Akshat Kulshestra. The case was argued by senior advocate Ramji Srinivasan.